Drug Profile
Stearyl norleucine vasointestinal peptide
Alternative Names: SNV; Stearyl norleucine VIPLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial sources
- Developer Senetek
- Class
- Mechanism of Action Vasoactive intestinal peptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction; Female sexual dysfunction
Most Recent Events
- 05 Nov 2002 No development reported - Preclinical for Erectile dysfunction in USA (Topical)
- 05 Nov 2002 No development reported - Preclinical for Female sexual dysfunction in USA (Topical)
- 25 Sep 2000 Preclinical development for Erectile dysfunction in USA (Topical)